Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 6256 AL 6270

Risk factors that affect life expectancy in Alzheimer's disease: a 15-year follow-up

Wattmo C, Londos E, Minthon L.

Dement Geriatr Cogn Disord. 2014;38(5-6):286-99. doi: 10.1159/000362926. Epub 2014 Jul 3.

Meta-analysis of the association between CR1 polymorphisms and risk of late-onset Alzheimer's disease

Luo J, Li S, Qin X, Song L, Peng Q, Chen S, Xie Y, Xie L, Li T, He Y, Deng Y, Wang J, Zeng Z.

Neurosci Lett. 2014 Aug 22;578:165-70. doi: 10.1016/j.neulet.2014.06.055. Epub 2014 Jul 1.

Computerized and virtual reality cognitive training for individuals at high risk of cognitive decline: systematic review of the literature

Coyle H, Traynor V, Solowij N.

Am J Geriatr Psychiatry. 2015 Apr;23(4):335-359. doi: 10.1016/j.jagp.2014.04.009. Epub 2014 May 14.

Is socioeconomic status a predictor of mortality in nonagenarians? The vitality 90+ study

Enroth L, Raitanen J, Hervonen A, Nosraty L, Jylhä M.

Age Ageing. 2015 Jan;44(1):123-9. doi: 10.1093/ageing/afu092. Epub 2014 Jul 7.

Longitudinal inflammation, cognitive decline, and Alzheimer's disease: a mini-review

Bettcher BM, Kramer JH.

Clin Pharmacol Ther. 2014 Oct;96(4):464-9. doi: 10.1038/clpt.2014.147. Epub 2014 Jul 10.

Vascular cognitive impairment in dementia

Etherton-Beer CD.

Maturitas. 2014 Oct;79(2):220-6. doi: 10.1016/j.maturitas.2014.06.004. Epub 2014 Jun 14.

Total cholesterol and neuropsychiatric symptoms in Alzheimer's disease: the impact of total cholesterol level and gender

Hall JR, Wiechmann AR, Johnson LA, Edwards M, Barber RC, Cunningham R, Singh M, O'Bryant SE.

Dement Geriatr Cogn Disord. 2014;38(5-6):300-9. doi: 10.1159/000361043. Epub 2014 Jul 4.

Plasma proteins predict conversion to dementia from prodromal disease

Hye A, Riddoch-Contreras J, Baird AL, Ashton NJ, Bazenet C, Leung R, Westman E, Simmons A, Dobson R, Sattlecker M, Lupton M, Lunnon K, Keohane A, Ward M, Pike I, Zucht HD, Pepin D, Zheng W, Tunnicliffe A, Richardson J, Gauthier S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S.

Alzheimers Dement. 2014 Nov;10(6):799-807.e2. doi: 10.1016/j.jalz.2014.05.1749. Epub 2014 Jul 8.

Inflammatory risk factors and pathologies promoting Alzheimer's disease progression: is RAGE the key?

Matrone C, Djelloul M, Taglialatela G, Perrone L.

Histol Histopathol. 2015 Feb;30(2):125-39. doi: 10.14670/HH-30.125. Epub 2014 Jul 11.

Multiple or mixed cerebral microbleeds and dementia in patients with vascular risk factors

Miwa K, Tanaka M, Okazaki S, Yagita Y, Sakaguchi M, Mochizuki H, Kitagawa K.

Neurology. 2014 Aug 12;83(7):646-53. doi: 10.1212/WNL.0000000000000692. Epub 2014 Jul 11.

[Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia]

Bidzan M, Bidzan L.

Psychiatr Pol. 2014 Mar-Apr;48(2):319-30.

Memory concerns, memory performance and risk of dementia in patients with mild cognitive impairment

Wolfsgruber S, Wagner M, Schmidtke K, Frölich L, Kurz A, Schulz S, Hampel H, Heuser I, Peters O, Reischies FM, Jahn H, Luckhaus C, Hüll M, Gertz HJ, Schröder J, Pantel J, Rienhoff O, Rüther E, Henn F, Wiltfang J, Maier W, Kornhuber J, Jessen F.

PLoS One. 2014 Jul 14;9(7):e100812. doi: 10.1371/journal.pone.0100812. eCollection 2014.

Current understanding of the neurobiology and longitudinal course of geriatric depression

Weisenbach SL, Kumar A.

Curr Psychiatry Rep. 2014 Sep;16(9):463. doi: 10.1007/s11920-014-0463-y.

Typicality of words produced on a semantic fluency task in amnesic mild cognitive impairment: linguistic analysis and risk of conversion to dementia

Vita MG, Marra C, Spinelli P, Caprara A, Scaricamazza E, Castelli D, Canulli S, Gainotti G, Quaranta D.

J Alzheimers Dis. 2014;42(4):1171-8. doi: 10.3233/JAD-140570.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias